These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36328007)

  • 1. ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
    Pearson ADJ; de Rojas T; Karres D; Reaman G; Scobie N; Fox E; Lesa G; Ligas F; Norga K; Nysom K; Pappo A; Weigel B; Weiner S; Vassal G
    Lancet Oncol; 2022 Nov; 23(11):1354-1357. PubMed ID: 36328007
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
    Pearson ADJ; de Rojas T; Karres D; Reaman G; Scobie N; Fox E; Lesa G; Ligas F; Norga K; Nysom K; Pappo A; Weigel B; Weiner SL; Vassal G
    J Natl Cancer Inst; 2024 Feb; 116(2):200-207. PubMed ID: 37975877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
    Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
    Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Zwaan CM; Kolb EA; Karres D; Guillot J; Kim SY; Marshall L; Tasian SK; Smith M; Cooper T; Adamson PC; Barry E; Benettaib B; Binlich F; Borgman A; Brivio E; Capdeville R; Delgado D; Faller D; Fogelstrand L; Fraenkel PG; Hasle H; Heenen D; Kaspers G; Kieran M; Klusmann JH; Lesa G; Ligas F; Mappa S; Mohamed H; Moore A; Morris J; Nottage K; Reinhardt D; Scobie N; Simko S; Winkler T; Norga K; Reaman G; Vassal G
    Eur J Cancer; 2020 Sep; 136():116-129. PubMed ID: 32688206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
    Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.
    Pearson ADJ; Scobie N; Norga K; Ligas F; Chiodin D; Burke A; Minard-Colin V; Adamson P; Marshall LV; Balakumaran A; Benettaib B; Bhargava P; Bollard CM; Bolotin E; Bomken S; Buechner J; Burkhardt B; Caron H; Copland C; Demolis P; Egorov A; Farhan M; Zugmaier G; Gross T; Horton-Taylor D; Klapper W; Lesa G; Marcus R; Miles RR; Nottage K; Pacaud L; Ricafort R; Schrappe M; Sterba J; Vezan R; Weiner S; Kim SY; Reaman G; Vassal G
    Eur J Cancer; 2019 Mar; 110():74-85. PubMed ID: 30772656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to boost drug development in paediatric oncology.
    Daems S; Stevens H; Dewatripont M; Eichler HG; Goldman M
    Nat Rev Drug Discov; 2023 Oct; 22(10):769-770. PubMed ID: 37607983
    [No Abstract]   [Full Text] [Related]  

  • 8. ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
    Pearson ADJ; Weiner SL; Adamson PC; Karres D; Reaman G; Rousseau R; Blanc P; Norga K; Skolnik J; Kearns P; Scobie N; Barry E; Marshall LV; Knox L; Caron H; Wariabharaj D; Pappo A; DuBois SG; Gore L; Kieran M; Weigel B; Fox E; Nysom K; de Rojas T; Vassal G
    Eur J Cancer; 2022 May; 166():145-164. PubMed ID: 35290915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European regulatory strategy for supporting childhood cancer therapy developments.
    Karres D; Lesa G; Ligas F; Benchetrit S; Galluzzo S; Van Malderen K; Sterba J; van Dartel M; Renard M; Sisovsky P; Wang S; Norga K
    Eur J Cancer; 2022 Dec; 177():25-29. PubMed ID: 36323049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of paediatric neuro-oncological information on the Internet in German language].
    Bartels U; Hargrave D; Lau L; Esquembre C; Humpl T; Bouffet E
    Klin Padiatr; 2003; 215(6):352-7. PubMed ID: 14677102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of the National Childhood Cancer Registry in the field of paediatric oncology care in Hungary].
    Garami M; Schuler D; Jakab Z
    Orv Hetil; 2014 May; 155(19):732-9. PubMed ID: 24796778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RACE to accelerate drug development for children with cancer.
    Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672
    [No Abstract]   [Full Text] [Related]  

  • 13. Paediatric drug development and evaluation: Existing challenges and recommendations.
    Kaguelidou F; Ouèdraogo M; Treluyer JM; Le Jeunne C; Annereau M; Blanc P; Bureau S; Ducassou S; Fiquet B; Flamein F; Gaillard S; Hankard R; Laugel V; Laurent C; Levy C; Marquet T; Polak M; Portefaix A; Vassal G
    Therapie; 2023; 78(1):105-114. PubMed ID: 36528416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of the Brazilian telehealth network for paediatric oncology.
    Hira AY; Lopes TT; de Mello AN; Filho VO; Zuffo MK; de Deus Lopes R
    J Telemed Telecare; 2005; 11 Suppl 2():S51-2. PubMed ID: 16375796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development.
    Concin N; Ray-Coquard I; Glasspool RM; Braicu E; Farrelly L; Votan B; Mirza MR; Gonzalez Martin A; Vergote I; Pignata S
    Int J Gynecol Cancer; 2020 Jun; 30(6):730-734. PubMed ID: 32404377
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.
    Shebley M; Menon RM; Gibbs JP; Dave N; Kim SY; Marroum PJ
    J Clin Pharmacol; 2019 May; 59(5):625-637. PubMed ID: 30562405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing an internet-based paediatric cancer registration and communication system for the Hungarian paediatric oncology network.
    Borgulya G; Jakab Z; Schuler D; Garami M
    Stud Health Technol Inform; 2004; 105():44-50. PubMed ID: 15718593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
    Hansford JR
    J Paediatr Child Health; 2019 Jan; 55(1):10-12. PubMed ID: 30499210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making paediatric oncological research relevant.
    Saha V
    Hosp Med; 2002 Jan; 63(1):54. PubMed ID: 11828822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.